NCT03465150 Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital
| NCT ID | NCT03465150 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Acne |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2018-09-23 |
| Primary Completion | 2033-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2018-09-23 with a primary completion date of 2033-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
With 24 million results associated with Google's searchon keywords "severe acne", Pr Dreno's team understand better thatthis disease, which affects many French people, is a real concern of Public Health and not a "forced evil" of the adolescent period, which will eventually resolve itself. Acne does not affect the vital prognosis, but its psychosocial impact is major and should not be underestimated. Paradoxically, despite the high prevalence of acne, few quality epidemiological studies have been published. Physicians are often helpless when faced with patients' questions. They often need a lot of explanations, especially on the factors aggravating this dermatosis, which greatly affects their quality of life. This cohort, the first of its kind in France, will determine the predictive factors of therapeutic response, endogenous and environmental factors impacting on the severity of acne assess the quality of life and psychological impact of acne patients, determine the patient's course of care and the associated costs. Pr Dreno's team will also build up a bio collection (bacteriological samples).
Eligibility Criteria
Inclusion Criteria: * Patient with acne * Patient (or parents/guardians for minors) who are not opposed to participating in the cohort. * Subjects affiliated to an appropriate health insurance Exclusion Criteria: * Dermatosis of the face other than acne * Refusal to participate by the minor or parent/guardian * Adults under a legal protection regime (guardianship, trusteeship, judicial safeguard)
Contact & Investigator
Brigitte DRENO, PU-PH
PRINCIPAL INVESTIGATOR
Nantes University Hospital
Frequently Asked Questions
Who can join the NCT03465150 clinical trial?
This trial is open to participants of all sexes, studying Acne. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03465150 currently recruiting?
Yes, NCT03465150 is actively recruiting participants. Contact the research team at brigitte.dreno@wanadoo.fr for enrollment information.
Where is the NCT03465150 trial being conducted?
This trial is being conducted at Nantes, France.
Who is sponsoring the NCT03465150 clinical trial?
NCT03465150 is sponsored by Nantes University Hospital. The principal investigator is Brigitte DRENO, PU-PH at Nantes University Hospital. The trial plans to enroll 200 participants.